Glucolepidiin potassium salt
| Product Name | Glucolepidiin potassium salt |
|---|---|
| Alternate Names | - Carbohydrates, Carbohydrates of - |
| CAT No. | CS-O-49089 |
| CAS No. | 245550-55-4 |
| Category | Carbohydrates |
| Stock | Enquire |
| Mol. Wt. | 386.46 g/mol |
| Mol. For. | C9H17NO9S2.K |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | - |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Get an Instant Quote
Related Compounds
iGB4Cer d18:1/18:0-Biotin (GalNAcb1,3Gala1,3Galb1,4GlcbCeramide-Biotin) | GM1asph d18:1 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbSphingolipids) | GlcCer d20:1/18:0 (GlcbCeramide) | GD3Cer d20:1/16:0 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | iGB3Cer d18:1/18:0-Biotin (Gala1,3Galb1,4GlcbCeramide-Biotin) | GM1aCer d20:1/8:0 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GD1aCer d20:1/18:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM3sph d18:1 (Neu5Aca2,3Galb1,4GlcbSphingolipids) | GM2 | Fucose 1-phosphate | GM3Cer d20:1/8:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | GQ3Cer d18:1/20:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | Pk(Gala1,4Galb1,4GlcbR) | Neu5Aca2,3Galb1,4(Fuca1,3)(HSO4-6-)GlcNAc | NeuAca2, 6Galb1, 4GlcNAc | GT3Cer d18:1/18:0-Biotin (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide-Biotin) | Lewis Y (Le Y) | GD3Cer d20:1/24:1 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GD3Cer d20:1/12:0 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | FucGM1Cer d18:1/18:0-Biotin ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide-Biotin) | iGloboHCer d18:1/18:0-Biotin ((Fuca1,2)Galb1,3GalNAcb1,3Gala1,3Galb1,4GlcbCeramide-Biotin) | Sialyl-Lc4 | GlcNAcproN3 | GM3Cer d18:1/8:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | FucGM1Cer d18:1/8:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | Epiprogoitrin potassium salt | GT1cCer d18:1/12:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GD1aCer d18:1/18:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GD1aCer d20:1/24:1 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | Ac3 6-AzManNAc | Ac3 6AzGalNAc | A-Antigen-Cer d18:1/18:0-Biotin (GalNAca1,3(Fuca1,2)Galb1,4GlcbCeramide-Biotin) | GQ3Cer d18:1/16:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GT2Cer d18:1/24:1 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | Glucoiberin potassium salt | GM2Cer d18:1/16:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GQ3Cer d20:1/24:1 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | FucGM1Cer d20:1/20:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GD1bCer d18:1/8:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | Blood type trisaccharide H Type II | GM2Cer d18:1/8:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM1aCer d20:1/16:0 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | Glucoerucin potassium salt | GT3Cer d18:1/18:0-Biotin (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide-Biotin) | Gluconapin | GT1cCer d18:1/18:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GlcNAcb1, 3Galb1, 4GlcNAc | GD3Cer d18:1/24:1 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GD3Cer d18:1/8:0 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GlcCer d20:1/20:0 (GlcbCeramide) | GT1cCer d20:1/8:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GT1cCer d18:1/20:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GM1bCer d18:1/20:0 (Neu5Aca2,3Galb1,3GalNAcb1,4Galb1,4GlcbCeramide) | Ac3 GlcNAcproN3 | GQ3sph d20:1 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbSphingolipids) | GD1bCer d20:1/16:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | LewisaCer d20:1/24:1-Biotin (Galb1,3(Fuca1,4)GlcNAcb1,3Galb1,4GlcbCeramide-Biotin) | GD1aCer d18:1/20:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | FucGM1Cer d20:1/8:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM1bCer d20:1/8:0 (Neu5Aca2,3Galb1,3GalNAcb1,4Galb1,4GlcbCeramide) | GB4Cer d18:1/18:0-Biotin (GalNAcb1,3Gala1,4Galb1,4GlcbCeramide-Biotin) | C24:1 β-Glucosylceramide | SSEA-4 | GT2Cer d18:1/8:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | FucGM1sph d20:1 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbSphingolipids) | GM1aCer d18:1/8:0 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | Galc d18:1/18:1（GalaCeramide） | GT2 | GM2Cer d18:1/20:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | Gb5 |